Delivery Order SPE2DB25D3306-SPE2DB25FUCRS
- Not listed
- The Defense Logistics Agency awarded a $19,456.34 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on July 22, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Venclexta is a prescription medication used in the treatment of certain blood cancers, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of VENCLEXTA 100 mg on July 31, 2025, with a ceiling value of $19,456.34. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. VENCLEXTA is a prescription medication used in the treatment of chronic lymphocytic leukemia and other hematologic malignancies, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Venclexta 50 mg tablet unit dose packages (quantity 7). This non-set-aside, competitively awarded contract is valued at $1,743.06 with a firm fixed price and is scheduled for completion by September 4, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for the supply of VENCLEXTA 100 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. VENCLEXTA is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,728.17 to supply Venclexta 100 mg tablets (120-count units) with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 28 units, with a ceiling value of $2,289.70. This is a firm fixed-price delivery order with no set-aside designation, issued competitively. The contract is expected to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCRSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on August 21, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. Venclexta is a specialized oncology medication used in the treatment of chronic lymphocytic leukemia and other blood cancers, reflecting the Defense Logistics Agency's pharmaceutical procurement mission for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp leverages this expansive contract vehicle to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. The firm fixed-price delivery order structure demonstrates the company's established capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/21/25 |